Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan
- PMID: 26558819
- DOI: 10.1161/HYPERTENSIONAHA.115.06260
Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan
Abstract
High nighttime and early morning blood pressure (BP) have been associated with greater risk for cardiovascular events than high clinic or daytime BP. BP is typically highest in the rising hours, when morning activities typically begin. We examined the effect of renal denervation on morning (6:00-8:59 AM), daytime (9:00 AM-8:59 PM), and nighttime (1:00-5:59 AM) ambulatory BP. Patient data from 2 prospective, randomized controlled trials of patients with treatment-resistant, uncontrolled hypertension, one conducted in a US population (Renal Denervation in Patients With Uncontrolled Hypertension [SYMPLICITY HTN-3]) and the other in a Japanese population (SYMPLICITY HTN-Japan [HTN-Japan]), were analyzed. Patients in SYMPLICITY HTN-3 and HTN-Japan were prescribed a similar number of baseline antihypertensive medications (5.2±1.4 versus 4.9±1.6, P=0.28), but the classes prescribed and changes in prescription varied by study. Among patients treated with renal denervation, although the number of ablation treatments were similar in both studies (11.2±2.8 versus 11.5±1.9, P=0.55), patients in SYMPLICITY HTN-3 were less likely to receive at least 1 four-quadrant ablation treatment (25% versus 82%, P<0.001). In SYMPLICITY HTN-3, compared with controls (n=159), patients treated with renal denervation (n=325) experienced a significantly greater change in morning (-7.3±19.8 mm Hg, P<0.001) and nighttime (-6.1±18.2 versus -1.6±19.7 mm Hg, P=0.02) but not daytime systolic BP (-7.2±16.2 versus -6.4±18.6 mm Hg, P=0.67). This same trend was observed in the pooled analysis with HTN-Japan. Reduction of BP during these high-risk periods might provide cardiovascular protection in drug-resistant hypertensive patients, although this will need to be proved in future randomized trials.
Clinical trial registration: URL: www.clinicaltrials.gov; Unique identifiers: NCT01418261 (SYMPLICITY HTN-3) and NCT01644604 (HTN-Japan).
Keywords: SYMPLICITY; ambulatory blood pressure monitoring; blood pressure; denervation; hypertension.
© 2015 American Heart Association, Inc.
Similar articles
-
Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.J Am Coll Cardiol. 2014 Sep 16;64(11):1071-8. doi: 10.1016/j.jacc.2014.05.012. Epub 2014 May 20. J Am Coll Cardiol. 2014. PMID: 24858423 Clinical Trial.
-
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18. Lancet. 2022. PMID: 36130612 Clinical Trial.
-
Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).Hypertension. 2017 Mar;69(3):494-500. doi: 10.1161/HYPERTENSIONAHA.116.08448. Epub 2017 Jan 23. Hypertension. 2017. PMID: 28115517 Clinical Trial.
-
Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?J Am Soc Hypertens. 2015 Feb;9(2):140-9. doi: 10.1016/j.jash.2014.12.002. Epub 2014 Dec 11. J Am Soc Hypertens. 2015. PMID: 25649995 Review.
-
What are the ideal metrics for assessing the quality of long-term stabilized "perfect" 24-h BP control after renal denervation?Hypertens Res. 2024 Oct;47(10):2644-2651. doi: 10.1038/s41440-024-01859-5. Epub 2024 Aug 28. Hypertens Res. 2024. PMID: 39191961 Review.
Cited by
-
Systemic Hemodynamic Atherothrombotic Syndrome and Resonance Hypothesis of Blood Pressure Variability: Triggering Cardiovascular Events.Korean Circ J. 2016 Jul;46(4):456-67. doi: 10.4070/kcj.2016.46.4.456. Epub 2016 Jul 21. Korean Circ J. 2016. PMID: 27482253 Free PMC article. Review.
-
Renal denervation: are we at a crossroads?Neth Heart J. 2016 Jul;24(7-8):447-8. doi: 10.1007/s12471-016-0856-0. Neth Heart J. 2016. PMID: 27277790 Free PMC article. No abstract available.
-
Key Points of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension.Korean Circ J. 2019 Dec;49(12):1123-1135. doi: 10.4070/kcj.2019.0246. Korean Circ J. 2019. PMID: 31760704 Free PMC article. Review.
-
2022 Malaysian Working Group Consensus Statement on Renal Denervation for management of arterial hypertension.Hypertens Res. 2022 Jul;45(7):1111-1122. doi: 10.1038/s41440-022-00937-w. Epub 2022 Jun 1. Hypertens Res. 2022. PMID: 35650248 Free PMC article.
-
The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study.J Clin Hypertens (Greenwich). 2018 Mar;20(3):438-446. doi: 10.1111/jch.13199. Epub 2018 Feb 13. J Clin Hypertens (Greenwich). 2018. PMID: 29436105 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical